Lead sponsor
Cuibai Wei，Clinical Professor
1 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
1
Trials led
1
Ongoing
120
Total enrollment
1
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Not applicable
1
Trials by status
Recruiting
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
The Clinical Study of Synaptic Plasticity-based Lencanumab for the Treatment of Early Alzheimer's DiseaseAmyloid biomarker required (PET/CSF)N/ARecruiting120